Qiling Tang
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Curcumin's Biomedical Applications
Papers in
-
- RNA modifications and cancer 4
- Genomics, phytochemicals, and oxidative stress 3
- Cell death mechanisms and regulation 2
- RNA Research and Splicing 2
- Oncology 5
- Peptidase Inhibition and Analysis 3
- Co-authors
- Xiaoli Zheng (1 shared paper)Junkai Zhang (1 shared paper)Lvyuan Li (3 shared papers)Qianjin Liao (2 shared papers)Zhaoyang Zeng (3 shared papers)Wenwen Zheng (3 shared papers)Chenyu Guo (3 shared papers)Xiaoping Wang (4 shared papers)
- Journals
- Cancer Medicine (2 papers)Cytometry Part A (2 papers)Cell Death Discovery (1 paper)Biochemical and Biophysical Research Communications (1 paper)Oncogene (1 paper)
- Partner nations
- ChinaSaudi Arabia
In The Last Decade
Qiling Tang
19 papers receiving 371 citations
Peers
Comparison fields: 5 of 64
- Cancer Research 110
- Molecular Medicine 25
- Molecular Biology 222
- Complementary and alternative medicine 16
- Oncology 47
Countries citing papers authored by Qiling Tang
This map shows the geographic impact of Qiling Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiling Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiling Tang more than expected).
Fields of papers citing papers by Qiling Tang
This network shows the impact of papers produced by Qiling Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiling Tang. The network helps show where Qiling Tang may publish in the future.
Co-authors
The 25 scholars most cited alongside Qiling Tang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 93 | |
| 2 | 2018 | 48 | |
| 3 | 2022 | 33 | |
| 4 | 2017 | 32 | |
| 5 | 2015 | 27 | |
| 6 | 2019 | 26 | |
| 7 | 2016 | 21 | |
| 8 | 2020 | 15 | |
| 9 | 2021 | 12 | |
| 10 | 2014 | 12 | |
| 11 | 2022 | 11 | |
| 12 | 2020 | 10 | |
| 13 | 2019 | 7 | |
| 14 | 2022 | 7 | |
| 15 | 2024 | 6 | |
| 16 | 2021 | 5 | |
| 17 | 2021 | 5 | |
| 18 | A preliminary study on the anticancer efficacy of Caulis spatholobi compound 1802. | 2018 | 3 |
| 19 | 2025 | 2 |
About Qiling Tang
Qiling Tang is a scholar working on Molecular Biology, Oncology, Cancer Research, Immunology and Plant Science, having authored 19 papers that have together received 375 indexed citations. Recurring topics across this work include RNA modifications and cancer (4 papers), Genomics, phytochemicals, and oxidative stress (3 papers), Peptidase Inhibition and Analysis (3 papers), Cell death mechanisms and regulation (2 papers), Phytochemistry and Biological Activities (2 papers), Flavonoids in Medical Research (2 papers), RNA Research and Splicing (2 papers) and NF-κB Signaling Pathways (2 papers). The work is most often cited by research in Cancer Research (110 citations), Molecular Medicine (25 citations), Molecular Biology (222 citations), Complementary and alternative medicine (16 citations) and Oncology (47 citations). Qiling Tang has collaborated with scholars based in China and Saudi Arabia. Frequent co-authors include Xiaoli Zheng, Junkai Zhang, Lvyuan Li, Qianjin Liao, Zhaoyang Zeng, Wenwen Zheng, Chenyu Guo, Xiaoping Wang, Shengqiang Yu and Wei Xiong. Their work appears in journals such as Cancer Medicine, Cytometry Part A, Cell Death Discovery, Biochemical and Biophysical Research Communications and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.